Peritoneal implantation of pheochromocytoma following tumor capsule rupture during surgery

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 12, 2014, Pages E2681-E2685

  Rafat, Cedric ^a,b   Zinzindohoue, Franck ^a,b   Hernigou, Anne ^a,b   Hignette, Chantal ^a,b   Favier, Judith ^c   Tenenbaum, Florence ^a,d   Gimenez Roqueplo, Anne Paule ^a,b,c   Plouin, Pierre Francois ^a,b,c   Amar, Laurence ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^d Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; PENTETREOTIDE IN 111; VANILMANDELIC ACID; CREATININE; METADRENALIN;

ADULT; ARTICLE; BONE METASTASIS; BRAIN SCINTISCANNING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PERITONEUM METASTASIS; PHEOCHROMOCYTOMA; RETROPERITONEUM; TUMOR CAPSULE RUPTURE; TUMOR GROWTH; TUMOR LOCALIZATION; ADRENAL GLAND NEOPLASMS; CASE REPORT; CHROMAFFIN CELL; PATHOLOGY; PERITONEAL NEOPLASMS; RECURRENT DISEASE; REOPERATION; RUPTURE; URINE;

ADRENAL GLAND NEOPLASMS; ADULT; CHROMAFFIN CELLS; CREATININE; FEMALE; HUMANS; MALE; METANEPHRINE; MIDDLE AGED; PERITONEAL NEOPLASMS; PHEOCHROMOCYTOMA; RECURRENCE; REOPERATION; RUPTURE;

EID: 84916618544     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1975     Document Type: Article

References (20)

1. Plouin PF, Chatellier G, Fofol I, Corvol P. Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension. 1997;29:1133-1139.
2. Amar L, Fassnacht M, Gimenez-Roqueplo AP, et al. Long-term post-operative follow-up in patients with apparently benign pheochromocytoma and paraganglioma. Horm Metab Res. 2012;44:385-389.
3. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47:207-214.
4. Vanderveen KA, Thompson SM, Callstrom MR, et al. Biopsy of pheochromocytomas and paragangliomas: potential for disaster. Surgery. 2009;146:1158-1166.
5. Deckers S, Derdelinckx L, Col V, Hamels J, Maiter D. Peritoneal carcinomatosis following laparoscopic resection of an adrenocortical tumor causing primary hyperaldosteronism. Horm Res. 1999;52:97-100.
6. Foxius A, Ramboux A, Lefebvre Y, Broze B, Hamels J, Squifflet J. Hazards of laparoscopic adrenalectomy for Conn's adenoma. When enthusiasm turns to tragedy. Surg Endosc. 1999;13:715-717.
7. Li ML, Fitzgerald PA, Price DC, Norton JA. Iatrogenic pheochromocytomatosis: a previously unreported result of laparoscopic adrenalectomy. Surgery. 2001;130:1072-1077.
8. Héron E, Chatellier G, Billaud E, Foos E, Plouin PF. The urinary metanephrine-to-creatinine ratio for the diagnosis of pheochromocytoma. Ann Intern Med. 1996;125:300-303.
9. Hermanek P, Wittekind C. Residual tumor (R) classification and prognosis. Semin Surg Oncol. 1994;10:12-20.
10. FIRSTMAPP. Clinical trial. Study title: first international randomized study in malignant progressive pheochromocytoma and paraganglioma (PPGL). www.firstmappp.fr. Published May 15, 2014. Accessed October 28, 2014.
11. Hescot S, Leboulleux S, Amar L, et al. One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2013;98:4006-4012.
12. Scholz T, Schulz C, Klose S, Lehnert H. Diagnostic management of benign and malignant pheochromocytoma. Exp Clin Endocrinol Diabetes. 2007;115:155-159.
13. Letouzé E, Martinelli C, Loriot C, et al. SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma. Cancer Cell. 2013;23:739-752.
14. Agarwal A, Mehrotra PK, Jain M, et al. Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy? World J Surg. 2010;34:3022-3028.
15. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab. 2005;90:2110-2116.
16. Lee BR, Tan BJ, Smith AD. Laparoscopic port site metastases: incidence, risk factors, and potential preventive measures. Urology. 2005;65:639-644.
17. Wilhelm SM, Prinz RA, Barbu AM, Onders RP, Solorzano CC. Analysis of large versus small pheochromocytomas: operative approaches and patient outcomes. Surgery. 2006;140:553-559; discussion 559-560.
18. Ippolito G, Palazzo FF, Sebag F, Thakur A, Cherenko M, Henry JF. Safety of laparoscopic adrenalectomy in patients with large pheochromocytomas: a single institution review. World J Surg. 2008;32:840-844; discussion 845-846.
19. Mathew G, Watson DI, Ellis T, De Young N, Rofe AM, Jamieson GG. The effect of laparoscopy on the movement of tumor cells and metastasis to surgical wounds. Surg Endosc. 1997;11:1163-1166.
20. Bergamini C, Martellucci J, Tozzi F, Valeri A. Complications in laparoscopic adrenalectomy: the value of experience. Surg Endosc. 2011;25:3845-3851.